These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 14751963)

  • 1. Modeling the relationship between LVAD support time and gene expression changes in the human heart by penalized partial least squares.
    Huang X; Pan W; Park S; Han X; Miller LW; Hall J
    Bioinformatics; 2004 Apr; 20(6):888-94. PubMed ID: 14751963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term mechanical unloading and reverse remodeling of failing hearts in children.
    Mohapatra B; Vick GW; Fraser CD; Clunie SK; Towbin JA; Sinagra G; Vatta M
    J Heart Lung Transplant; 2010 Jan; 29(1):98-104. PubMed ID: 19783184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial expression of the arginine:glycine amidinotransferase gene is elevated in heart failure and normalized after recovery: potential implications for local creatine synthesis.
    Cullen ME; Yuen AH; Felkin LE; Smolenski RT; Hall JL; Grindle S; Miller LW; Birks EJ; Yacoub MH; Barton PJ
    Circulation; 2006 Jul; 114(1 Suppl):I16-20. PubMed ID: 16820567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy.
    Barton PJ; Felkin LE; Birks EJ; Cullen ME; Banner NR; Grindle S; Hall JL; Miller LW; Yacoub MH
    Circulation; 2005 Aug; 112(9 Suppl):I46-50. PubMed ID: 16159864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of extracellular matrix genes during myocardial recovery from heart failure after left ventricular assist device support.
    Felkin LE; Lara-Pezzi E; George R; Yacoub MH; Birks EJ; Barton PJ
    J Heart Lung Transplant; 2009 Feb; 28(2):117-22. PubMed ID: 19201335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
    Daneshmand MA; Rajagopal K; Lima B; Khorram N; Blue LJ; Lodge AJ; Hernandez AF; Rogers JG; Milano CA
    Ann Thorac Surg; 2010 Apr; 89(4):1205-9; discussion 1210. PubMed ID: 20338335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy.
    Hall JL; Birks EJ; Grindle S; Cullen ME; Barton PJ; Rider JE; Lee S; Harwalker S; Mariash A; Adhikari N; Charles NJ; Felkin LE; Polster S; George RS; Miller LW; Yacoub MH
    Eur Heart J; 2007 Mar; 28(5):613-27. PubMed ID: 17132651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential gene expression and genomic patient stratification following left ventricular assist device support.
    Blaxall BC; Tschannen-Moran BM; Milano CA; Koch WJ
    J Am Coll Cardiol; 2003 Apr; 41(7):1096-106. PubMed ID: 12679207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global gene expression analysis in nonfailing and failing myocardium pre- and postpulsatile and nonpulsatile ventricular assist device support.
    Schwientek P; Ellinghaus P; Steppan S; D'Urso D; Seewald M; Kassner A; Cebulla R; Schulte-Eistrup S; Morshuis M; Röfe D; El Banayosy A; Körfer R; Milting H
    Physiol Genomics; 2010 Aug; 42(3):397-405. PubMed ID: 20460602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Borrowing information from relevant microarray studies for sample classification using weighted partial least squares.
    Huang X; Pan W; Han X; Chen Y; Miller LW; Hall J
    Comput Biol Chem; 2005 Jun; 29(3):204-11. PubMed ID: 15979040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
    Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed messages: transcription patterns in failing and recovering human myocardium.
    Margulies KB; Matiwala S; Cornejo C; Olsen H; Craven WA; Bednarik D
    Circ Res; 2005 Mar; 96(5):592-9. PubMed ID: 15718504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
    Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How does successful bridging with ventricular assist device affect cardiac transplantation outcome?
    Urban M; Pirk J; Dorazilova Z; Netuka I
    Interact Cardiovasc Thorac Surg; 2011 Oct; 13(4):405-9. PubMed ID: 21788304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic profiling of the human failing heart after left ventricular assist device support.
    de Weger RA; Schipper ME; Siera-de Koning E; van der Weide P; van Oosterhout MF; Quadir R; Steenbergen-Nakken H; Lahpor JR; de Jonge N; Bovenschen N
    J Heart Lung Transplant; 2011 May; 30(5):497-506. PubMed ID: 21211997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
    Klotz S; Danser AH; Foronjy RF; Oz MC; Wang J; Mancini D; D'Armiento J; Burkhoff D
    J Am Coll Cardiol; 2007 Mar; 49(11):1166-74. PubMed ID: 17367660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support.
    Birks EJ; Hall JL; Barton PJ; Grindle S; Latif N; Hardy JP; Rider JE; Banner NR; Khaghani A; Miller LW; Yacoub MH
    Circulation; 2005 Aug; 112(9 Suppl):I57-64. PubMed ID: 16159866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNFalpha in patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device.
    Bruggink AH; van Oosterhout MF; De Jonge N; Gmelig-Meyling FH; De Weger RA
    Transpl Immunol; 2008 Apr; 19(1):64-8. PubMed ID: 18346639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered myocardial Ca2+ cycling after left ventricular assist device support in the failing human heart.
    Chaudhary KW; Rossman EI; Piacentino V; Kenessey A; Weber C; Gaughan JP; Ojamaa K; Klein I; Bers DM; Houser SR; Margulies KB
    J Am Coll Cardiol; 2004 Aug; 44(4):837-45. PubMed ID: 15312868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.